{"output": [["BioNTech", "ORG", "Raise", "$270 million", "ECON_INDICATOR"], ["BioNTech", "ORG", "Operate_In", "Germany", "GPE"], ["BioNTech", "ORG", "Has", "war chest", "ECON_INDICATOR"], ["BioNTech", "ORG", "Go_Public_In", "stock market", "FIN_INSTRUMENT"], ["BioNTech", "ORG", "Participates_In", "cancer treatment", "CONCEPT"], ["BioNTech", "ORG", "Control", "personalized cancer vaccine", "PRODUCT"], ["BioNTech", "ORG", "Work_On", "other cancer-fighting technologies", "CONCEPT"], ["BioNTech", "ORG", "Collaborate_With", "Roche", "ORG"], ["BioNTech", "ORG", "Collaborate_With", "Eli Lilly", "ORG"], ["BioNTech", "ORG", "Collaborate_With", "Sanofi", "ORG"], ["BioNTech", "ORG", "Collaborate_With", "Genmab", "ORG"], ["BioNTech", "ORG", "Collaborate_With", "Bayer Animal Health", "ORG"], ["BioNTech", "ORG", "Bankrolled_By", "Struengmanns", "PERSON"], ["BioNTech", "ORG", "Latest_Financing_Includes", "Redmile Group", "ORG"], ["BioNTech", "ORG", "Latest_Financing_Includes", "Janus Henderson Investors", "ORG"], ["BioNTech", "ORG", "Latest_Financing_Includes", "Invus", "ORG"], ["BioNTech", "ORG", "Latest_Financing_Includes", "Fidelity", "ORG"], ["BioNTech", "ORG", "Latest_Financing_Includes", "European family offices", "ORG"]], "published": "2018-01-04T09:30:00.000+02:00"}